FDA Expands Investigation on Heels of Latest Tylenol Recall

May 23, 2014
by Adler Markoff & Associates

Request A Free Consultation

(405) 607-8757

    FDA Expands Investigation on Heels of Latest Tylenol Recall

    The makers of Tylenol, Motrin, Benadryl and other over-the-counter medications has come under increasingly intense scrutiny recently because of a series of recalls and other serious problems. McNeil is the manufacturer of these medications, and McNeil is a subsidiary of Johnson & Johnson, one of the true giants of the corporate world. Unfortunately for many people, McNeil medication products have generated hundreds of adverse effects reports. Now comes word that the FDA, on the heels of a recently completed investigation of one of McNeil’s manufacturing plants, has announced that it will expand its investigation. This news adds to the problems the company is having that has already prompted calls for help to defective drugs lawyers all over the United States.


    Just within the last six months, there have been at least four different McNeil medication recalls initiated by the company. Three of them appear to be related in that two were expansions of the original McNeil medication recall in November of 2009. Ultimately, these three McNeil medication recalls removed all of the lots of Tylenol Arthritis Pain 100 count with the EZ-open cap as well as an undisclosed number of Tylenol, Motrin and other over-the-counter drugs.

    These recalls were started because consumers reported that they became nauseous and sick because of the smell that emanated from inside the container of these medications. In addition, on May 1st of this year, McNeil initiated a fourth recall of several children’s versions of these products because of the discovery of dangerous bacteria in the manufacturing process.


    Within this time frame of McNeil medication recalls, the FDA also released a report of its findings concerning an investigation into one of McNeil’s manufacturing plants that is located in Fort Washington, Pennsylvania. The FDA report was scathing in nature, and it detailed at least 20 serious problems with the manufacturing process of these drugs, the lack of proper precautions and sanitation in the manufacturing environment and the lack of any response by McNeil to at least 46 consumer adverse effects reports that were traced back to this facility. As a result of all of these problems, the FDA has announced an expansion of its investigation to all other manufacturing facilities used by McNeil.


    Overall, there have been 775 adverse effects reports dealing with Tylenol side effects and negative reactions to other products manufactured by McNeil, and 37 people have died after using these products despite the fact that no definitive link has yet been established between their use of these medications and their tragic results. If you or someone you love has been harmed by these McNeil medications, contact the Oklahoma defective drugs lawyers at AMA Law immediately to schedule a free initial consultation.

    Request a free consultation

    (405) 607-8757